Page 1106 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

65. White NJ, Warrell DA, Bunnag D, Looareesuwan S, 71. Dunser MW, Festic E, Dondorp A, et al. Recommendations for
Chongsuphajaisiddi T, Harinasuta T. Quinidine in falciparum sepsis management in resource-limited settings. Intensive Care
malaria. Lancet. 1981:1069-1071. Med. April 2012;38(4):557-574.
66. White NJ, Looareesuwan S, Warrell DA. Quinine and quinidine: 72. Dunser MW, Festic E, Dondorp A, et al. Erratum to: recom-
a comparison of EKG effects during the treatment of malaria. mendations for sepsis management in resource-limited settings.
J Cardiovasc Pharmacol. 1983;5:173-175. Intensive Care Med. April 2012;38(4):575-576.
67. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among 73. Krishna S, Supanaranond W, Pukrittayakamee S, et al.
children admitted to a rural hospital in Kenya. N Engl J Med. Dichloroacetate for lactic acidosis in severe malaria: a phar-
January 6, 2005;352(1):39-47. macokinetic and pharmacodynamic assessment. Metabolism.
68. Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange 1994;43:974-981.
transfusion as an adjunct therapy in severe Plasmodium fal- 74. Agbenyega T, Planche T, Bedu-Addo G, et al. Population kinet-
ciparum malaria: a meta-analysis. Clin Infect Dis. May 1, ics, efficacy, and safety of dichloroacetate for lactic acidosis
2002;34(9):1192-1198. due to severe malaria in children. J Clin Pharmacol. April
69. White NJ, Looareesuwan S, Phillips RE, Chantavanich P, 2003;43(4):386-396.
Warrell DA. Single dose phenobarbitone prevents convulsions
in cerebral malaria. Lancet. 1988;ii:64-66.
70. Crawley J, Waruiru C, Mithwani S, et al. Effect of phenobarbi-
tal on seizure frequency and mortality in childhood cerebral
malaria: a randomised, controlled intervention study. Lancet.
February 26, 2000;355(9205):701-706.

Section05-O-ref.indd 3 1/20/2015 4:51:25 PM